<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
AGIO
Agios Pharmaceuticals
$
()


  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    3/14/2024 - 12:50pm
  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    3/14/2024 - 11:41am
  • Biotech Alert: Searches spiking for these stocks today

    2/26/2024 - 11:01am
  • Agios Pharmaceuticals reports 2023 EPS ($6.33), consensus ($6.26)

    2/15/2024 - 07:03am
  • Agios Pharmaceuticals initiated with bullish view at Cantor Fitzgerald, here's why

    2/8/2024 - 07:21am
  • Agios Pharmaceuticals price target raised by $1 at JPMorgan, here's why

    1/23/2024 - 07:00am
  • Agios Pharmaceuticals announces anticipated 2024 milestones

    1/8/2024 - 07:35am
  • Biotech Alert: Searches spiking for these stocks today

    1/5/2024 - 11:01am
  • Agios Pharmaceuticals: Phase 3 ENERGIZE study met primary endpoint

    1/3/2024 - 06:31am
  • Agios presents results from Phase 2 portion of RISE UP pivotal study

    12/10/2023 - 06:59am
  • Agios announces clinical proof-of-concept Phase 2a trial of AG-946

    11/20/2023 - 07:03am
  • Agios Pharmaceuticals reports Q3 EPS ($1.64), consensus ($1.70)

    11/2/2023 - 07:12am
  • Viridian Therapeutics appoints Gheuens to its board of directors

    9/25/2023 - 08:06am
  • Agios Pharmaceuticals announces license agreement with Alnylam

    8/3/2023 - 08:19am
  • Agios Pharmaceuticals reports Q2 EPS ($1.51), consensus ($1.56)

    8/3/2023 - 07:25am
dynamic_feed Breaking News